GENOVA, Inc. (TYO:9341)
Japan · Delayed Price · Currency is JPY | Market Cap | 10.26B -17.4% |
| Revenue (ttm) | 11.57B +15.6% |
| Net Income | 275.40M -80.5% |
| EPS | 15.74 -80.1% |
| Shares Out | 17.34M |
| PE Ratio | 37.61 |
| Forward PE | n/a |
| Dividend | 30.00 (4.94%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 18,100 |
| Open | 592.00 |
| Previous Close | 592.00 |
| Day's Range | 585.00 - 593.00 |
| 52-Week Range | 541.00 - 752.00 |
| Beta | -0.13 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 10, 2026 |
About GENOVA
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital. In addition, the company offers NOMOCa-Stand, a smart and simple automatic payment and reception machine; NOMOCa-Regi, a self-pay mac... [Read more]
Financial Performance
In fiscal year 2026, GENOVA's revenue was 11.57 billion, an increase of 15.58% compared to the previous year's 10.01 billion. Earnings were 275.00 million, a decrease of -80.54%.
Financial StatementsNews
Check Your Pantry ASAP for This Recalled Canned Tuna Brand
Tri-Union Seafoods announced a recall of canned tuna sold under the Trader Joe's, Genova, Van Camp's and H-E-B brand names due to quality and safety concerns.